Rebalix
Amundi · sheet of 10 September 2026
Amundi · sheet of 10 September 2026ETF sheet · official issuer and register data
Amundi DIVDAX UCITS ETF Dist
C003 · LU2611731741 · class UCITS ETF Dist · EUR · domicile Luxembourg
Equity · EurozoneSFDR art. 6
Index tracked: DivDAX Total Return Index
- TER
- 0.25%+ trans. 0.01%
- Fund size
- 86 m EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingannual
Launch 7 Dec 2023 · costs from the KID as of 2 Sept 2026 · 16 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Sub-Fund is an index-tracking UCITS passively managed. The objective of this Sub-Fund is to track the performance of the DivDAX Total Return Index (the “Index”), and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is a Net Total Return Index: dividends net of tax paid by the Index constituents are included in the Index return. The Index is an equity index…
Performance since series start (in euro) — base 100
29 Nov 2023 → 8 Sept 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +14.2% |
| 3 years | series too young |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +43.4% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 14.19% | 14.19% | — |
| Max drawdown | −9.89% | −9.89% | — |
| Sharpe | 0.60 | 0.60 | — |
| Sortino | 0.83 | 0.83 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · C003 · LU26117317411
RebalixC003 · LU2611731741 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +21.80% | +22.86% | −1.06% |
Distributions · per share, in EUR
Frequency: annual · last 12 months: 1.33 EUR (3.36% of NAV) · last ex-date 9 Dec 2025
| Year | Payments | Total (EUR) | Dividend yield |
|---|---|---|---|
| 2025 | 1 | 1.33 | +4.21% |
| 2024 | 1 | 1.17 | +3.73% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 1 Sept 2026 · 16 securities · top-10 weight = 86.9%
| Top holdings | Weight |
|---|---|
| 11.1% | |
| 10.7% | |
| 10.2% | |
| 10.2% | |
| 9.6% | |
| 9.3% | |
| 9.1% | |
| 6.8% | |
| 5.7% | |
| 4.4% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
— · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
C003 · Xetra (Deutsche Börse)
+ 14 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU2611731741
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU2611731741
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · C003 · LU26117317412